Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902.
- Citation:
- J Clin Oncol vol 34 (suppl) abstr 2029
- Meeting Instance:
- ASCO 2016
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Parents:
- None
- Children:
- 2578
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- S. Keith Anderson C. Ryan Miller Jann N. Sarkaria Kurt A. Jaeckle Jan C. Buckner Keith L. Ligon Karla V. Ballman Dennis F. Moore Jr. Manmeet S. Ahluwalia Eudocia Quant Lee Elise Hovarth Elizabeth Gerstner Glenn J. Lesser Michael Prados Stuart A. Grossman Caterina Giannini Patrick Y. Wen Evanthia Galanis
- Networks:
- CA011, CA824, GEISINGER, KS055, LAPS-MA036, LAPS-MN026, LAPS-NC007, NC002
- Study
- NCCTG-N0874
- Multiple Studies, or Legacy Studies in Alliance Study:
- ABTC-0902
- Phases:
- 1/2, 1/2
- Keywords: